Mimedx (MDXG) Non Operating Income (2023 - 2026)
Mimedx (MDXG) reported Non Operating Income of $886000.0 for Q1 2026, up 75.1% on a YoY basis from $506000.0 in Q1 2025, and down 1.99% sequentially from $904000.0 in Q4 2025.
Mimedx (MDXG) Non Operating Income (2023 - 2026) Analysis & Trends
Mimedx (MDXG) has 4 years of Non Operating Income data on file, last reported at $886000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 75.1% year-over-year to $886000.0; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 178.4% YoY), and the FY2025 full-year result was $2.9 million, up 391.55% from the prior year.
- Non Operating Income fell to $886000.0 in Q1 2026, from $904000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $904000.0 in Q4 2025 to a low of -$1.7 million in Q1 2024.
- A 4-year average of -$174166.7 and a median of $340500.0 in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 24500.0% in 2025 and jumped 75.1% in 2026, its largest moves.
- Tracing MDXG's Non Operating Income over 4 years: stood at -$1.6 million in 2023, then soared by 125.3% to $403000.0 in 2024, then jumped by 124.32% to $904000.0 in 2025, then decreased by 1.99% to $886000.0 in 2026.
- Business Quant data shows MDXG's Non Operating Income at $886000.0 in Q1 2026, $904000.0 in Q4 2025, and $785000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 886,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 886,000.00 |
| Dec 31, 2025 | 904,000.00 |
| Sep 30, 2025 | 785,000.00 |
| Jun 30, 2025 | 738,000.00 |
| Mar 31, 2025 | 506,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 278,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -1.69 Mn |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | -1.68 Mn |
| Jun 30, 2023 | -1.63 Mn |